Hospital surgical volume, utilization, costs and outcomes of retroperitoneal lymph node dissection for testis cancer

33Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Objectives. Retroperitoneal lymph node dissection (RPLND) outcomes for testis cancer originate mostly from single-center series. We characterized population-based utilization, costs, and outcomes and assessed whether higher volume affects outcomes. Methods and Materials. Using the US Nationwide Inpatient Sample from 2001-2008, we identified 993 RPLND and used propensity score methods to assess utilization, costs, and inpatient outcomes based on hospital surgical volume. Results. 51.6 of RPLND were performed at hospitals where there were two or fewer cases per year. RPLND was more commonly performed at large urban teaching hospitals, where men were younger, more likely to be white and earning incomes exceeding the 50th percentile (all P≤.05). Higher hospital volumes were associated with fewer complications and more routine home discharges (all P ≤ .047). However, higher volume hospitals had more transfusions (P=.004) and incurred 1,435 more in median costs (P

Cite

CITATION STYLE

APA

Yu, H. Y., Hevelone, N. D., Patel, S., Lipsitz, S. R., & Hu, J. C. (2012). Hospital surgical volume, utilization, costs and outcomes of retroperitoneal lymph node dissection for testis cancer. Advances in Urology. https://doi.org/10.1155/2012/189823

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free